ProMetic Life Sciences Inc.

Presenter: Pierre Laurin, President and Chief Executive Officer

Company Information

Company Type: Therapeutics

Development Stage: Public

Company Profile

ProMetic is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission of bringing to market effective, innovative, lower cost products for the treatment of hematological and nephrological disorders and cancer. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East. ProMetic focuses its activities in the Protein Technologies and Therapeutics markets.

Contact

ProMetic Life Sciences Inc.
8168 chemin Montview
Mount-Royal
Quebec, Canada
H4P 2L7

ph: 514 341 2115
fx: 514 341 6227

www.prometic.com
a.leduc@prometic.com